Locally Advanced Unresectable Triple-Negative Breast Carcinoma: Clinical Trials

1 trial for Locally Advanced Unresectable Triple-Negative Breast Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Locally Advanced Unresectable Triple-Negative Breast Carcinoma: new trials by email Literature Review of Locally Advanced Unresectable Triple-Negative Breast Carcinoma trials Research Report on Locally Advanced Unresectable Triple-Negative Breast Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer
Biopsy, Biospecimen Collection, Computed Tomography - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8
Phase 2RecruitingRoswell Park Cancer Institute302026-03-032026-04-24

Narrower conditions

Triple Negative Breast Neoplasms (1)

Broader conditions

Breast Diseases (1)  ·  Breast Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Biopsy (1)  ·  Doxorubicin (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Specimen Handling (1)  ·  Tamoxifen (1)  ·  liposomal doxorubicin (1)

Sponsors

Roswell Park Cancer Institute (1)

Countries

United States (1)

Top investigators

Sheheryar Kabraji (1)